HUTCHMED (China) Limited

HCM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$38$101-$360-$167
Dep. & Amort.$12$8$9$7
Deferred Tax$0-$103$0-$115
Stock-Based Comp.$22$37$31$42
Change in WC-$62$71$59$32
Other Non-Cash-$9$105-$6-$4
Operating Cash Flow$0$219-$269-$204
Investing Activities
PP&E Inv.-$18-$33-$37-$17
Net Acquisitions$0-$3$0$159
Inv. Purchases-$1,849-$1,628-$1,202-$1,371
Inv. Sales/Matur.$1,769$1,372$1,518$921
Other Inv. Act.$1$0$16$1
Investing Cash Flow-$96-$291$297-$306
Financing Activities
Debt Repay.$6$62-$9-$1
Stock Issued$1$5$0$717
Stock Repurch.-$36-$9-$48-$27
Dividends Paid$0$0-$87-$100
Other Fin. Act.-$1-$9$62$60
Financing Cash Flow-$31$49-$83$650
Forex Effect-$3-$6-$9$2
Net Chg. in Cash-$130-$30-$64$142
Supplemental Information
Beg. Cash$284$313$378$236
End Cash$154$284$313$378
Free Cash Flow-$17$187-$305-$221